Home › Companies › 89BIO INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and 89BIO INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 29, 2024: 5 items on 89BIO INC.’s Form 8-K, filed May 31, 2024: 3 elected · 2 passed (calculated).
Significant dissent: 1 director (48.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore 89BIO INC. in the interactive database Compare manager voting policies
These tallies are 89BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Steven M. Altschuler, M.D. | 78,767,873 | -- | -- | 870,306 | 5,519,919 | 99% | Elected | — |
| Elect Director: Michael Hayden, M.B. Ch.B., Ph.D. | 74,810,576 | -- | -- | 4,827,603 | 5,519,919 | 94% | Elected | — |
| Elect Director: Kathleen LaPorte | 41,297,162 | -- | -- | 38,341,017 | 5,519,919 | 51.9% | Elected | — |
| 2. Ratification of KPMG LLP as Independent Auditor | 85,047,829 | 21,903 | 88,366 | -- | 0 | 99.9% | Passed (calculated) | — |
| 3. Advisory Vote on Executive Compensation | 78,521,244 | 1,100,672 | 16,263 | -- | 5,519,919 | 99% | Passed (calculated) | — |
Source: 89BIO INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
167 asset managers disclosed a vote on at least one 89BIO INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of 89BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
51.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte
89BIO INC.’s own tally for this item (“Elect Director: Kathleen LaPorte”): 41,297,162 for, 38,341,017 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received the plurality of votes on Proposal 4, and each of the other proposals voted on were approved.”
Support: 51.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 2,003,063 | 0 | 0 | 2,998,333 | Mixed |
| Vanguard | 4,515,216 | 0 | 0 | 0 | For |
| State Street | 34,656 | 0 | 0 | 3,213,121 | Withhold |
| BlackRock | 0 | 0 | 0 | 2,926,902 | Withhold |
| Fidelity | 1,075,163 | 0 | 0 | 38,788 | For |
| HARBOR FUNDS | 3,587 | 0 | 1,001,160 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 0 | 632,031 | Withhold |
| Aberdeen | 0 | 0 | 0 | 470,387 | Withhold |
| TIAA | 459,872 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 254,237 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 247,680 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 206,953 | 0 | Abstain |
| Equitable | 0 | 0 | 0 | 198,339 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 138,399 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 112,783 | Withhold |
| ProShares | 0 | 0 | 0 | 92,652 | Withhold |
| Nushares ETF Trust | 87,914 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 78,480 | Withhold |
| Morgan Stanley | 0 | 0 | 0 | 44,300 | Withhold |
| Harbor Funds II | 43,541 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 40,434 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 38,968 | Withhold |
| Global X | 0 | 0 | 0 | 28,309 | Withhold |
| John Hancock | 0 | 0 | 27,721 | 0 | Abstain |
| Pacific Life | 0 | 0 | 0 | 26,397 | Withhold |
Fund voting reports, all 49 managers: 8,262,397 for, 11,751,949 withheld, 1,258,474 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 653,000 | Withhold |
Institutional-manager reports, all 1 managers: 653,000 withheld.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: To be elected for terms expiring in 2027: Michael Hayden, M.B. Ch.B., Ph.D.
89BIO INC.’s own tally for this item (“Elect Director: Michael Hayden, M.B. Ch.B., Ph.D.”): 74,810,576 for, 4,827,603 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received the plurality of votes on Proposal 4, and each of the other proposals voted on were approved.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,001,396 | 0 | 0 | 0 | For |
| Vanguard | 4,515,216 | 0 | 0 | 0 | For |
| State Street | 135,435 | 0 | 0 | 3,112,342 | Withhold |
| BlackRock | 2,926,902 | 0 | 0 | 0 | For |
| Fidelity | 1,113,951 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,004,747 | 0 | 0 | 0 | For |
| Charles Schwab | 632,031 | 0 | 0 | 0 | For |
| Aberdeen | 470,387 | 0 | 0 | 0 | For |
| TIAA | 459,872 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 254,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 247,680 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 206,953 | 0 | 0 | 0 | For |
| Equitable | 198,339 | 0 | 0 | 0 | For |
| Goldman Sachs | 138,399 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 112,783 | 0 | 0 | 0 | For |
| ProShares | 92,652 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 87,914 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,380 | 0 | 0 | 52,100 | Mixed |
| Morgan Stanley | 44,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 43,541 | 0 | 0 | 0 | For |
| Northern Trust | 40,434 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 38,968 | 0 | 0 | 0 | For |
| Global X | 28,309 | 0 | 0 | 0 | For |
| John Hancock | 27,721 | 0 | 0 | 0 | For |
| Pacific Life | 26,397 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 18,103,380 for, 3,169,440 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 653,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 653,000 for.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: To be elected for terms expiring in 2027: Steven Altschuler, M.D.
89BIO INC.’s own tally for this item (“Elect Director: Steven M. Altschuler, M.D.”): 78,767,873 for, 870,306 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received the plurality of votes on Proposal 4, and each of the other proposals voted on were approved.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,001,396 | 0 | 0 | 0 | For |
| Vanguard | 4,515,216 | 0 | 0 | 0 | For |
| State Street | 3,244,181 | 0 | 0 | 3,596 | For |
| BlackRock | 2,926,902 | 0 | 0 | 0 | For |
| Fidelity | 1,113,951 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,004,747 | 0 | 0 | 0 | For |
| Charles Schwab | 632,031 | 0 | 0 | 0 | For |
| Aberdeen | 470,387 | 0 | 0 | 0 | For |
| TIAA | 459,872 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 254,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 247,680 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 206,953 | 0 | 0 | 0 | For |
| Equitable | 198,339 | 0 | 0 | 0 | For |
| Goldman Sachs | 138,399 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 112,783 | 0 | 0 | 0 | For |
| ProShares | 92,652 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 87,914 | 0 | 0 | 0 | For |
| Lincoln Financial | 78,480 | 0 | 0 | 0 | For |
| Morgan Stanley | 44,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 43,541 | 0 | 0 | 0 | For |
| Northern Trust | 40,434 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 38,968 | 0 | 0 | 0 | For |
| Global X | 28,309 | 0 | 0 | 0 | For |
| John Hancock | 27,721 | 0 | 0 | 0 | For |
| Pacific Life | 26,397 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 21,261,338 for, 11,482 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 653,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 653,000 for.
Combines 7 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
89BIO INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 78,521,244 for, 1,100,672 against, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,001,396 | 0 | 0 | 0 | For |
| Vanguard | 4,515,216 | 0 | 0 | 0 | For |
| State Street | 3,247,777 | 0 | 0 | 0 | For |
| BlackRock | 2,926,902 | 0 | 0 | 0 | For |
| Fidelity | 1,113,951 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,004,747 | 0 | 0 | 0 | For |
| Charles Schwab | 632,031 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 470,387 | 0 | 0 | Against |
| TIAA | 459,872 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 254,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 247,680 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 206,953 | 0 | 0 | 0 | For |
| Equitable | 198,339 | 0 | 0 | 0 | For |
| Goldman Sachs | 138,399 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 112,783 | 0 | 0 | 0 | For |
| ProShares | 92,652 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 87,914 | 0 | 0 | 0 | For |
| Lincoln Financial | 78,480 | 0 | 0 | 0 | For |
| Morgan Stanley | 44,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 43,541 | 0 | 0 | 0 | For |
| Northern Trust | 40,434 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 38,968 | 0 | 0 | 0 | For |
| Global X | 28,309 | 0 | 0 | 0 | For |
| John Hancock | 27,721 | 0 | 0 | 0 | For |
| Pacific Life | 26,397 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 20,794,547 for, 478,273 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 11,894,575 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 11,105,732 | 0 | 0 | 0 | For |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,371 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 4,491,727 | 0 | 0 | 0 | For |
| State Street | 4,437,077 | 0 | 0 | 0 | For |
| BVF INC/IL | 4,006,576 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 3,400,426 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 2,349,827 | 0 | 0 | 0 | For |
| BlackRock | 2,159,270 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 2,054,466 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,667,044 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,185,407 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 980,978 | 0 | 0 | 0 | For |
| Holocene Advisors, LP | 975,388 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 827,371 | 0 | 0 | 0 | For |
| Orchard Capital Management, LLC | 696,469 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 653,000 | 0 | 0 | 0 | For |
| Citadel | 644,121 | 0 | 0 | 0 | For |
| Charles Schwab | 632,031 | 0 | 0 | 0 | For |
| Nuveen | 553,944 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 470,387 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 450,000 | 0 | 0 | 0 | For |
| Northern Trust | 448,973 | 80 | 0 | 0 | For |
| EAGLE ASSET MANAGEMENT INC | 431,453 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 337,021 | 0 | 0 | 0 | For |
Institutional-manager reports, all 134 managers: 65,441,330 for, 882,546 against, 38,312 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| HARBOR FUNDS | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Nushares ETF Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Morgan Stanley | 0 | 0 | 0 | 0 | -- |
| Harbor Funds II | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 49 managers: 21,272,820 1 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 11,105,732 | 0 | Abstain |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BVF INC/IL | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| Laurion Capital Management LP | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MPM BioImpact LLC | 0 | 0 | 0 | 0 | -- |
| Holocene Advisors, LP | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| EAGLE ASSET MANAGEMENT INC | 0 | 0 | 0 | 0 | -- |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 126 managers: 38,589 for, 11,105,732 abstained, 53,325,493 1 year, 500 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 100.0% for (June 5, 2023 meeting) unchanged
Description as filed by funds: Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024.
89BIO INC.’s own tally for this item (“2. Ratification of KPMG LLP as Independent Auditor”): 85,047,829 for, 21,903 against, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,001,396 | 0 | 0 | 0 | For |
| Vanguard | 4,515,216 | 0 | 0 | 0 | For |
| State Street | 3,247,777 | 0 | 0 | 0 | For |
| BlackRock | 2,926,902 | 0 | 0 | 0 | For |
| Fidelity | 1,113,951 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,004,747 | 0 | 0 | 0 | For |
| Charles Schwab | 632,031 | 0 | 0 | 0 | For |
| Aberdeen | 470,387 | 0 | 0 | 0 | For |
| TIAA | 459,872 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 254,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 247,680 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 206,953 | 0 | 0 | 0 | For |
| Equitable | 198,339 | 0 | 0 | 0 | For |
| Goldman Sachs | 138,399 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 112,783 | 0 | 0 | 0 | For |
| ProShares | 92,652 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 87,914 | 0 | 0 | 0 | For |
| Lincoln Financial | 78,480 | 0 | 0 | 0 | For |
| Morgan Stanley | 44,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 43,541 | 0 | 0 | 0 | For |
| Northern Trust | 40,434 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 38,968 | 0 | 0 | 0 | For |
| Global X | 28,309 | 0 | 0 | 0 | For |
| John Hancock | 27,721 | 0 | 0 | 0 | For |
| Pacific Life | 26,397 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 21,272,820 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 653,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 653,000 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 95,199,724 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | JANUS INVESTMENT FUND | 5.25% |
| 2 | Vanguard | 4.74% |
| 3 | State Street | 3.41% |
| 4 | BlackRock | 3.07% |
| 5 | Fidelity | 1.17% |
| 6 | HARBOR FUNDS | 1.06% |
| 7 | Charles Schwab | 0.66% |
| 8 | Aberdeen | 0.49% |
| 9 | TIAA | 0.48% |
| 10 | FRANKLIN STRATEGIC SERIES | 0.27% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 12.49% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 11.67% |
| 3 | SUVRETTA CAPITAL MANAGEMENT, LLC | 6.13% |
| 4 | RTW INVESTMENTS, LP | 4.72% |
| 5 | State Street | 4.66% |
| 6 | BVF INC/IL | 4.21% |
| 7 | PICTET ASSET MANAGEMENT SA | 3.57% |
| 8 | Laurion Capital Management LP | 2.47% |
| 9 | BlackRock | 2.27% |
| 10 | Redmile Group, LLC | 2.16% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with RA Capital | 14,254,298 | 14.97% | Proxy statement (DEF 14A), proxy filed April 17, 2024 |
| BlackRock | 10,316,393 | 10.84% | Form 13F, quarter ended March 31, 2024 |
| Entities affiliated with Janus Henderson Group | 10,081,258 | 10.59% | Proxy statement (DEF 14A), proxy filed April 17, 2024 |
| Vanguard Group | 8,053,459 | 8.46% | Form 13F, quarter ended March 31, 2024 |
| S | 7,991,644 | 8.39% | Schedule 13G, filed October 17, 2024 |
| Entities affiliated with RTW Investments, LP | 5,578,931 | 5.86% | Proxy statement (DEF 14A), proxy filed April 17, 2024 |
| State Street | 5,543,588 | 5.82% | Form 13F, quarter ended March 31, 2024 |
| Entities affiliated with Suvretta Capital Management, LLC. | 4,888,434 | 5.13% | Proxy statement (DEF 14A), proxy filed April 17, 2024 |
| Citadel Advisors | 1,718,842 | 1.81% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 1,616,785 | 1.70% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 95,199,724 shares outstanding, as reported by 89BIO INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At 89BIO INC.'s shareholder meeting held May 29, 2024, in the 2023-2024 proxy season, 167 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,217 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: 89BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from 89BIO INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
89BIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Proxy Votes Now, “89BIO INC. 2024 Annual Meeting: Shareholder Vote Results & Fund Votes”, https://proxyvotesnow.com/company/89bio-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.